Topline results from the groundbreaking Salford Lung Study are encouraging for GSK's new respiratory drug - but the 'real world' story isn't quite so simple. GlaxoSmithKline (GSK) has announced ...

Long-standing inflammatory disorders, including COPD and GERD, signal heightened risk for lung cancer among never-smokers, ...

A pathbreaking imaging technique is set to change the way lung function is assessed by demonstrating the effect of treatments in real-time which can help in detection of decline in lung function ...